Drug class
Diagnostic ultrasound contrast agent; perfluorobutane gas-filled microbubble
Mechanism of action
Perflubutane microbubbles circulate intravascularly and strongly scatter ultrasound waves, enhancing vascular and tissue perfusion signals. In the liver, the stabilised microbubbles are taken up by Kupffer cells, allowing vascular and postvascular (Kupffer) phase imaging.
General use cases
- Contrast-enhanced ultrasound for evaluation of focal liver lesions in countries where Sonazoid is authorised.
- In Japan, also used for selected breast-lesion ultrasound imaging under the relevant product authorisation. The diagnostic agent is the formulated perflubutane microbubble product, not the gas alone.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
